These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10078276)
1. A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit. Plötz FB; van Oeveren W; Hultquist KA; Miller C; Bartlett RH; Wildevuur CR Artif Organs; 1992 Aug; 16(4):366-70. PubMed ID: 10078276 [TBL] [Abstract][Full Text] [Related]
2. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
3. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass. Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461 [TBL] [Abstract][Full Text] [Related]
4. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces. Kirschfink M; Kovacs B; Mottaghy K Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684 [TBL] [Abstract][Full Text] [Related]
5. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices. Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323 [TBL] [Abstract][Full Text] [Related]
6. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Wendel HP; Ziemer G Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants. Böning A; Scheewe J; Ivers T; Friedrich C; Stieh J; Freitag S; Cremer JT J Thorac Cardiovasc Surg; 2004 May; 127(5):1458-65. PubMed ID: 15116008 [TBL] [Abstract][Full Text] [Related]
8. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion. Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of new surface coatings for extracorporeal circulation. Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642 [TBL] [Abstract][Full Text] [Related]
10. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model. Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847 [TBL] [Abstract][Full Text] [Related]
11. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Lindholm L; Ouchterlony J Ann Thorac Surg; 2003 Mar; 75(3):919-25. PubMed ID: 12645717 [TBL] [Abstract][Full Text] [Related]
12. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902 [TBL] [Abstract][Full Text] [Related]